論文種別 | 原著(症例報告除く) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Osimertinib in poor performance status patients with T790M-positive non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B) |
掲載誌名 | 正式名:International Journal of Clinical Oncology |
掲載区分 | 国外 |
巻・号・頁 | 27(1),pp.112-120 |
著者・共著者 | Yukari Tsubata, Kana Watanabe, Ryota Saito, Atsushi Nakamura, Hiroshige Yoshioka, Mami Morita, Ryoichi Honda, Nobuhiro Kanaji, Satoshi Ohizumi, Daisuke Jingu, Taku Nakagawa, Kensuke Nakazawa, Atsuto Mouri, Susumu Takeuchi, Naoki Furuya, Yuki Akazawa, Kiyotaka Miura, Eiki Ichihara, Makoto Maemondo, Satoshi Morita, Kunihiko Kobayashi, Takeshi Isobe |
発行年月 | 2022/01 |
DOI | 10.1007/s10147-021-02043-2 |
PMID | 34643820 |